Related references
Note: Only part of the references are listed.Antibiotics-Driven Gut Microbiome Perturbation Alters Immunity to Vaccines in Humans
Thomas Hagan et al.
CELL (2019)
Patterns of systemic and local inflammation in patients with asthma hospitalised with influenza
Akhilesh Jha et al.
EUROPEAN RESPIRATORY JOURNAL (2019)
Early Oseltamivir After Hospital Admission Is Associated With Shortened Hospitalization: A 5-Year Analysis of Oseltamivir Timing and Clinical Outcomes
Jeremy Katzen et al.
CLINICAL INFECTIOUS DISEASES (2019)
The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults
Hannah E. Segaloff et al.
JOURNAL OF MEDICAL VIROLOGY (2018)
RIG-I and Other RNA Sensors in Antiviral Immunity
Kwan T. Chow et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 36 (2018)
Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies
Yao-Qing Chen et al.
CELL (2018)
Laboratory-confirmed respiratory infections as triggers for acute myocardial infarction and stroke: a self-controlled case series analysis of national linked datasets from Scotland
Charlotte Warren-Gash et al.
EUROPEAN RESPIRATORY JOURNAL (2018)
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013
Alessandro Cassini et al.
EUROSURVEILLANCE (2018)
Activation and Induction of Antigen-Specific T Follicular Helper Cells Play a Critical Role in Live-Attenuated Influenza Vaccine-Induced Human Mucosal Anti-influenza Antibody Response
Abdullah Aljurayyan et al.
JOURNAL OF VIROLOGY (2018)
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
A. Danielle Iuliano et al.
LANCET (2018)
Urgent challenges in implementing live attenuated influenza vaccine
Anika Singanayagam et al.
LANCET INFECTIOUS DISEASES (2018)
Unanswered questions about the 1918 influenza pandemic: origin, pathology, and the virus itself
John S. Oxford et al.
LANCET INFECTIOUS DISEASES (2018)
Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infection
Pin-Hung Lin et al.
MUCOSAL IMMUNOLOGY (2018)
Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza
Jake Dunning et al.
NATURE IMMUNOLOGY (2018)
Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection
Jeffrey C. Kwong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Chasing Seasonal Influenza - The Need for a Universal Influenza Vaccine
Catharine I. Paules et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Global influenza seasonality to inform country-level vaccine programs: An analysis of WHO FluNet influenza surveillance data between 2011 and 2016
Laura P. Newman et al.
PLOS ONE (2018)
Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design
Yushen Du et al.
SCIENCE (2018)
Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity
Marios Koutsakos et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
From Original Antigenic Sin to the Universal Influenza Virus Vaccine
Carole Henry et al.
TRENDS IN IMMUNOLOGY (2018)
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents
Frederick G. Hayden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Recommendations for Prevention and Control of Influenza in Children, 2018-2019
Yvonne A. Maldonado et al.
PEDIATRICS (2018)
Treatment of influenza with neuraminidase inhibitors
Kate R. Beard et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2018)
Inflammation induced by influenza virus impairs human innate immune control of pneumococcus
Simon P. Jochems et al.
NATURE IMMUNOLOGY (2018)
Back to the Future: Lessons Learned From the 1918 Influenza Pandemic
Kirsty R. Short et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials
Ryan E. Malosh et al.
CLINICAL INFECTIOUS DISEASES (2018)
Local Modulation of Antigen-Presenting Cell Development after Resolution of Pneumonia Induces Long-Term Susceptibility to Secondary Infections
Antoine Roquilly et al.
IMMUNITY (2017)
Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains
Seth J. Zost et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
Madhusudan Rajendran et al.
MBIO (2017)
Ten Strategies of Interferon Evasion by Viruses
Adolfo Garcia-Sastre
CELL HOST & MICROBE (2017)
Efficacy of Clarithromycin-Naproxen-Oseltamivir Combination in the Treatment of Patients Hospitalized for Influenza A(H3N2) Infection An Open-label Randomized, Controlled, Phase IIb/III Trial
Ivan F. N. Hung et al.
CHEST (2017)
Defining the antibody cross-reactome directed against the influenza virus surface glycoproteins
Raffael Nachbagauer et al.
NATURE IMMUNOLOGY (2017)
Vaccines in the Prevention of Viral Pneumonia
Clementine S. Fraser et al.
CLINICS IN CHEST MEDICINE (2017)
Contribution of innate immune cells to pathogenesis of severe influenza virus infection
Suzanne L. Cole et al.
CLINICAL SCIENCE (2017)
Exploiting Mucosal Immunity for Antiviral Vaccines
Akiko Iwasaki
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Broadening Horizons: New Antibodies Against Influenza
Katherine J. L. Jackson et al.
CELL (2016)
Statin Use and Hospital Length of Stay Among Adults Hospitalized With Community-acquired Pneumonia
Fiona Havers et al.
CLINICAL INFECTIOUS DISEASES (2016)
Influenza Vaccination
John J. Treanor
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
Katelyn M. Gostic et al.
SCIENCE (2016)
The host immune response in respiratory virus infection: balancing virus clearance and immunopathology
Amy H. Newton et al.
SEMINARS IN IMMUNOPATHOLOGY (2016)
Human influenza viruses and CD8+ T cell responses
Emma J. Grant et al.
CURRENT OPINION IN VIROLOGY (2016)
Relationship Between Upper Respiratory Tract Influenza Test Result and Clinical Outcomes Among Critically Ill Influenza Patients
Krishna P. Reddy et al.
OPEN FORUM INFECTIOUS DISEASES (2016)
The immunology of influenza virus-associated bacterial pneumonia
Keven M. Robinson et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
Universal influenza vaccines, science fiction or soon reality?
Rory D. de Vries et al.
EXPERT REVIEW OF VACCINES (2015)
Statin Treatment and Mortality: Propensity Score-Matched Analyses of 2007-2008 and 2009-2010 Laboratory-Confirmed Influenza Hospitalizations
Matthew R. Laidler et al.
OPEN FORUM INFECTIOUS DISEASES (2015)
Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis
Yi Zhang et al.
CRITICAL CARE (2015)
Low Titers of Serum Antibodies Inhibiting Hemagglutination Predict Fatal Fulminant Influenza A(H1N1) 2009 Infection
Amelie Guihot et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
T cell mediated immunity to influenza: mechanisms of viral control
Nicole L. La Gruta et al.
TRENDS IN IMMUNOLOGY (2014)
Effectiveness of neuraminidase inhibitors in reducing mortality in patients admitted to hospital with influenza A H1N1pdm09 virus infection: a meta-analysis of individual participant data
Stella G. Muthuri et al.
LANCET RESPIRATORY MEDICINE (2014)
Comparative community burden and severity of seasonal and pandemic influenza: results of the Flu Watch cohort study
Andrew C. Hayward et al.
LANCET RESPIRATORY MEDICINE (2014)
Correlates of protection against influenza infection in humans - on the path to a universal vaccine?
Chris Ka-fai Li et al.
CURRENT OPINION IN IMMUNOLOGY (2013)
Newer influenza antivirals, biotherapeutics and combinations
Frederick G. Hayden
INFLUENZA AND OTHER RESPIRATORY VIRUSES (2013)
Bacterial Coinfection in Influenza A Grand Rounds Review
Daniel S. Chertow et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
The Beneficial Effects of Neuraminidase Inhibitor Drug Therapy on Severe Patient Outcomes During the 2009-2010 Influenza A Virus Subtype H1N1 Pandemic
Fred Y. Aoki et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Global Concerns Regarding Novel Influenza A (H7N9) Virus Infections
Timothy M. Uyeki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Adaptation of novel H7N9 influenza A virus to human receptors
J. C. F. M. Dortmans et al.
SCIENTIFIC REPORTS (2013)
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study
Fatimah S. Dawood et al.
LANCET INFECTIOUS DISEASES (2012)
Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines
Glendie Marcelin et al.
REVIEWS IN MEDICAL VIROLOGY (2012)
Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009-2010 in the UK
Puja R. Myles et al.
THORAX (2012)
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
Christopher S. Ambrose et al.
VACCINE (2012)
Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection Analytic Strategy Using Propensity Scores
Sung-Han Kim et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Endothelial Cells Are Central Orchestrators of Cytokine Amplification during Influenza Virus Infection
John R. Teijaro et al.
CELL (2011)
Oseltamivir and Risk of Lower Respiratory Tract Complications in Patients With Flu Symptoms: A Meta-analysis of Eleven Randomized Clinical Trials
Miguel A. Hernan et al.
CLINICAL INFECTIOUS DISEASES (2011)
Emerging Influenza Antiviral Resistance Threats
Frederick G. Hayden et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
John J. Treanor et al.
VACCINE (2011)
The art of medicine Eyewitness accounts of the 1510 influenza pandemic in Europe
David M. Morens et al.
LANCET (2010)
Influenza vaccination: lessons learned from the pandemic (H1N1) 2009 influenza outbreak
P. J. M. Openshaw et al.
MUCOSAL IMMUNOLOGY (2010)
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective
Matt Shale et al.
Therapeutic Advances in Gastroenterology (2010)
Original Antigenic Sin Responses to Influenza Viruses
Jin Hyang Kim et al.
JOURNAL OF IMMUNOLOGY (2009)
Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review
Charlotte Warren-Gash et al.
LANCET INFECTIOUS DISEASES (2009)
Innate immune responses to influenza A H5N1: friend or foe?
Joseph Sriyal Malik Peiris et al.
TRENDS IN IMMUNOLOGY (2009)
Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: Implications for pandemic influenza preparedness
David M. Morens et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Influenza-associated pediatric mortality in the United States:: Increase of Staphylococcus aureus coinfection
Lyn Finelli et al.
PEDIATRICS (2008)
Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic
Rafi Ahmed et al.
NATURE IMMUNOLOGY (2007)
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia
Menno D. de Jong et al.
NATURE MEDICINE (2006)
Share Paper
